These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15675125)

  • 1. Are ANCA-associated vasculitides inherited?
    Hellmich B; Epplen JT; Gross WL
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S1-2. PubMed ID: 15675125
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA genes in ANCA-associated vasculitides.
    Griffith ME; Pusey CD
    Exp Clin Immunogenet; 1997; 14(3):196-205. PubMed ID: 9493788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Tervaert JW; Heeringa P
    Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides.
    Borgmann S; Haubitz M
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S79-86. PubMed ID: 15675141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antineutrophil cytoplasmic antibody-associated vasculitides.
    Seo P; Stone JH
    Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANCA vasculitis meets epigenetics--closing in on the molecular roots of disease.
    Zeisberg M
    Nephrol Dial Transplant; 2011 Apr; 26(4):1146-8. PubMed ID: 21273237
    [No Abstract]   [Full Text] [Related]  

  • 7. Newer insights into the aetiology and pathogenesis of myeloperoxidase associated autoimmunity.
    Schmitt WH
    Jpn J Infect Dis; 2004 Oct; 57(5):S7-8. PubMed ID: 15507771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides.
    Tervaert JW; Stegeman CA; Kallenberg CG
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):241-5. PubMed ID: 8946592
    [No Abstract]   [Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibody-associated vasculitis: autoinflammation, autodestruction and autoimmunity--key to new therapies.
    Lamprecht P; Gross WL
    Trends Immunol; 2008 Dec; 29(12):587-8. PubMed ID: 18951843
    [No Abstract]   [Full Text] [Related]  

  • 10. The pathogenesis of ANCA-associated vasculitides: old hypotheses and new insights.
    Hänsch GM; Iking-Konert C; Andrassy K
    Clin Nephrol; 2005 Dec; 64(6):460-4. PubMed ID: 16370160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive T-cell responses to myeloperoxidase in patients with antineutrophil cytoplasmic antibody-associated vasculitis and in healthy individuals.
    Seta N; Tajima M; Kobayashi S; Kawakami Y; Hashimoto H; Kuwana M
    Mod Rheumatol; 2008; 18(6):593-600. PubMed ID: 18806928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology and new therapeutic considerations in ANCA-associated vasculitides.
    Gross WL
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S47-8. PubMed ID: 15309793
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neutrophil polynuclear anticytoplasmic antibodies in systemic vasculitides].
    Guillevin L
    Rev Mal Respir; 2000 Jun; 17(3):623-8. PubMed ID: 10951957
    [No Abstract]   [Full Text] [Related]  

  • 14. Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?
    Brons RH; Kallenberg CG; Tervaert JW
    Rheum Dis Clin North Am; 2001 Nov; 27(4):833-48. PubMed ID: 11723767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of ANCA-associated vasculitis.
    Csernok E; Müller A; Gross WL
    Intern Med; 1999 Oct; 38(10):759-65. PubMed ID: 10526937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New insights into the pathogenesis of ANCA-positive vasculitides].
    Guilpain P; Guillevin L; Mouthon L
    Presse Med; 2007 May; 36(5 Pt 2):854-9. PubMed ID: 17350787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
    Gross WL
    Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitis.
    van Rossum AP; Limburg PC; Kallenberg CG
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S64-8. PubMed ID: 14740429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibodies: are they pathogenic?
    Specks U
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S7-12. PubMed ID: 15675127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.